v-Src-induced modulation of the calpain-calpastatin proteolytic system regulates transformation

Molecular and Cellular Biology

Volumn 22, Issue 1, 2002, Pages 257-269

  Carragher, N O ^a   Westhoff, M A ^a   Riley, D ^a   Potter, D A ^a   Dutt, P ^a   Elce, J S ^a   Greer, P A ^a   Frame, M C ^a  

^a BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALPAIN; CALPASTATIN; CYCLIN A; CYCLIN D; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; GENE PRODUCT; ONCOPROTEIN; PROTEIN KINASE P60; RETINOBLASTOMA PROTEIN;

ANIMAL CELL; ARTICLE; CELL CYCLE; CELL TRANSFORMATION; CHICK EMBRYO; CONTROLLED STUDY; EMBRYO; FIBROBLAST CULTURE; GENE OVEREXPRESSION; MALIGNANT TRANSFORMATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEGRADATION;

ACTINS; ANIMALS; CALCIUM-BINDING PROTEINS; CALPAIN; CDC2-CDC28 KINASES; CELL DIVISION; CELL SIZE; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; CHICK EMBRYO; CYCLIN A; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASES; CYCLINS; CYTOSKELETON; FEEDBACK, BIOCHEMICAL; FIBROBLASTS; FOCAL ADHESION KINASE 1; FOCAL ADHESION PROTEIN-TYROSINE KINASES; FOCAL ADHESIONS; GENES, MYC; GENES, RAS; IMMUNOHISTOCHEMISTRY; MICE; MICE, KNOCKOUT; MODELS, BIOLOGICAL; ONCOGENE PROTEIN P65(GAG-JUN); ONCOGENE PROTEIN PP60(V-SRC); ONCOGENE PROTEINS V-FOS; PROTEIN ISOFORMS; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE KINASES; RETINOBLASTOMA PROTEIN; TEMPERATURE;

ANIMALIA; GALLUS GALLUS;

EID: 0036132672     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.22.1.257-269.2002     Document Type: Article

References (64)

1. Disruption of the murine calpain small subunit gene, Capn4: Calpain is essential for embryonic development but not for cell growth and division
2. Calpain inhibitor 1 activates p53-dependent apoptosis in tumor cell lines
3. Involvement of calpain in diamideinduced cataract in cultured lenses
4. Regulation of calpain and calpastatin in differentiating myoblasts: mRNA levels, protein synthesis and stability
5. Postischemic administration of AK275, a calpain inhibitor, provides substantial protection against focal ischemic brain damage
6. Calpain as a novel target for treating acute neurodegenerative disorders
7. Colocalization of calcium-dependent protease II and one of its substrates at sites of cell adhesion
8. Differential expression of Rous Sarcoma virus-specific transformation parameters in enucleated cells
9. Calpastatin is up-regulated in response to hypoxia and is a suicide substrate to calpain after neonatal cerebral hypoxia-ischemia
10. Expression of calpain I messenger RNA in human renal cell carcinoma: Correlation with lymph node metastasis and histological type
11. No requirement for src family kinases for PDGF signaling in fibroblasts expressing SV40 large T antigen
12. Cleavage of focal adhesion kinase by different proteases during Src-regulated transformation and apoptosis: Distinct roles for calpain and caspases
13. Degraded collagen fragments promote rapid disassembly of smooth muscle focal adhesions that correlates with cleavage of pp125(FAK), paxillin, and talin
14. Mitogenesis of quiescent chick fibroblasts by v-Src: Dependence on events at the membrane leading to early changes in AP-1
15. Regulation of cyclin DI by calpain protease
16. Calcium-activated neutral protease (calpain) system: Structure, function, and regulation
17. Altered distributions of the cytoskeletal proteins vinculin and alpha-actinin in cultured fibroblasts transformed by Rous sarcoma virus
18. SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene
19. Linker insertion-deletion mutagenesis of the v-src gene: Isolation of host- and temperature-dependent mutants
20. The catalytic activity of Src is dispensable for translocation to focal adhesions but controls the turnover of these structures during cell motility
21. V-Src-induced degradation of focal adhesion kinase during morphological transformation of chicken embryo fibroblasts
22. Separation of v-Src-induced mitogenesis and morphological transformation by inhibition of AP-1
23. Ectopic expression of the erythrocyte band 3 anion exchange protein, using a new avian retrovirus vector
24. A link between cyclin A expression and adhesion-dependent cell cycle progression
25. Regulation of cell migration by the calcium-dependent protease calpain
26. Posttranslational regulation of the retinoblastoma gene family member p107 by calpain protease
27. Expression of the v-Src oncoprotein in fibroblasts disrupts normal regulation of the CDK inhibitor p27 and inhibits quiescence
28. Calpains: Intact and active?
29. Identification and characterization of inhibitory sequences in four repeating domains of the endogenous inhibitor for calcium-dependent protease
30. Regulation of the calpain-calpastatin system by membranes
31. Cellular transformation, tyrosine kinase oncogenes, and the cellular adhesion plaque
32. Calpain-dependent proteolysis of NF2 protein: Involvement in schwannomas and meningiomas
33. Cells transformed by Rous sarcoma virus release transforming growth factors
34. Proteolytic cleavage of human p53 by calpain: A potential regulator of protein stability
35. A comparison of the intracellular distribution of mu-calpain, m-calpain, and calpastatin in proliferating human A431 cells
36. Molecular diversity in amino-terminal domains of human calpastatin by exon skipping
37. Interactions between SV40 large-tumor antigen and the growth suppressor proteins pRB and p53
38. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes
39. Isolation of a Chinese hamster ovary, cell clone possessing decreased mu-calpain content and a reduced proliferative growth rate
40. Proteolysis of the calcium-dependent protease inhibitor by myocardial calcium-dependent protease
41. Inhibition of growth of human TE2 and C-33A cells by the cell-permeant calpain inhibitor benzyloxycarbonyl-Leu-Leu-Tyr diazomethyl ketone
42. Calpain: A cytosolic proteinase active at the membranes
43. The calpain-calpastatin system and cellular proliferation and differentiation in rodent osteoblastic cells
44. Calpain-calpastatin interactions in epidermoid carcinoma KB cells
45. Cross-talk between two cysteine protease families. Activation of caspase-12 by calpain in apoptosis
46. Fragmentation of an endogenous inhibitor upon complex formation with high- and low-Ca2+-requiring forms of calcium-activated neutral proteases
47. Cell cycle regulation by the ubiquitin pathway
48. The sensitivity of c-Jun and c-Fos proteins to calpains depends on conformational determinants of the monomers and not on formation of dimers
49. Mitotic clonal expansion during preadipocyte differentiation: Calpain-mediated turnover of p27
50. Her-2/neu overexpression induces NF-kappaB via a P13-kinase/ Akt pathway involving calpain-mediated degradation of IkappaB-alpha that can be inhibited by the tumor suppressor PTEN
51. Calpain regulates actin remodeling during cell spreading
52. Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A
53. Mechanism of growth inhibition by calpain inhibitor in MCF-7 cells
54. Muscle-specific calpain, p94, responsible for limb girdle muscular dystrophy type 2A, associates with connectin through IS2, a p94-specific sequence
55. New era of calpain research. Discovery of tissue-specific calpains
56. Downregulation of calpastatin in rat heart after brief ischemia and reperfusion
57. Calpain activation in apoptosis
58. Calcium-activated neutral protease and its endogenous inhibitor. Activation at the cell membrane and biological function
59. Four types of calpastatin isoforms with distinct amino-terminal sequences are specified by alternative first exons and differentially expressed in mouse tissues
60. Changes in intracellular localization of calpastatin during calpain activation
61. Inhibition of the chymotrypsin-like activity of the pituitary, multicatalytic proteinase complex
62. A single point mutation has pleiotropic effects on pp60-function
63. Caspase-dependent activation of calpain during drug-induced apoptosis
64. 1 to S-phase transition